188 related articles for article (PubMed ID: 8031147)
21. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T
Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495
[TBL] [Abstract][Full Text] [Related]
22. Mutagenesis at a highly conserved phenylalanine in cytochrome P450 2E1 affects heme incorporation and catalytic activity.
Porter TD
Biochemistry; 1994 May; 33(19):5942-6. PubMed ID: 8180223
[TBL] [Abstract][Full Text] [Related]
23. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
[TBL] [Abstract][Full Text] [Related]
24. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
Wang H; Strobel HW
Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
[TBL] [Abstract][Full Text] [Related]
25. Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation.
Kempf AC; Zanger UM; Meyer UA
Arch Biochem Biophys; 1995 Aug; 321(2):277-88. PubMed ID: 7646052
[TBL] [Abstract][Full Text] [Related]
26. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
27. Expression of functionally active cytochrome b5 in Escherichia coli: isolation, purification, and use of the immobilized recombinant heme protein for affinity chromatography of electron-transfer proteins.
Chudaev MV; Usanov SA
Biochemistry (Mosc); 1997 Apr; 62(4):401-11. PubMed ID: 9275279
[TBL] [Abstract][Full Text] [Related]
28. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
[TBL] [Abstract][Full Text] [Related]
29. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human cytochrome P450 1B1 expression in Escherichia coli.
Shimada T; Wunsch RM; Hanna IH; Sutter TR; Guengerich FP; Gillam EM
Arch Biochem Biophys; 1998 Sep; 357(1):111-20. PubMed ID: 9721189
[TBL] [Abstract][Full Text] [Related]
31. Participation of rat liver cytochrome P450 2E1 in the activation of N-nitrosodimethylamine and N-nitrosodiethylamine to products genotoxic in an acetyltransferase-overexpressing Salmonella typhimurium strain (NM2009).
Yamazaki H; Oda Y; Funae Y; Imaoka S; Inui Y; Guengerich FP; Shimada T
Carcinogenesis; 1992 Jun; 13(6):979-85. PubMed ID: 1600620
[TBL] [Abstract][Full Text] [Related]
32. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
33. Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.
Kim RB; O'Shea D; Wilkinson GR
Pharmacogenetics; 1994 Jun; 4(3):162-5. PubMed ID: 7920697
[No Abstract] [Full Text] [Related]
34. Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene.
Speerschneider P; Dekant W
Toxicol Appl Pharmacol; 1995 Jan; 130(1):48-56. PubMed ID: 7839370
[TBL] [Abstract][Full Text] [Related]
35. Baculovirus expression and purification of human and rat cytochrome P450 2E1.
Chen W; Peter RM; McArdle S; Thummel KE; Sigle RO; Nelson SD
Arch Biochem Biophys; 1996 Nov; 335(1):123-30. PubMed ID: 8914842
[TBL] [Abstract][Full Text] [Related]
36. Oxidative and reductive metabolism by cytochrome P450 2E1.
Koop DR
FASEB J; 1992 Jan; 6(2):724-30. PubMed ID: 1537462
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 4A4: expression in Escherichia coli, purification, and characterization of catalytic properties.
Nishimoto M; Clark JE; Masters BS
Biochemistry; 1993 Aug; 32(34):8863-70. PubMed ID: 8364033
[TBL] [Abstract][Full Text] [Related]
38. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques.
Tassaneeyakul W; Veronese ME; Birkett DJ; Gonzalez FJ; Miners JO
Biochem Pharmacol; 1993 Dec; 46(11):1975-81. PubMed ID: 8267647
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off.
Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M
J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086
[TBL] [Abstract][Full Text] [Related]
40. Rabbit liver cytochrome P-450 2B5: high-level expression of the full-length protein in Escherichia coli, purification, and catalytic activity.
Lehnerer M; Schulze J; Petzold A; Bernhardt R; Hlavica P
Biochim Biophys Acta; 1995 Aug; 1245(1):107-15. PubMed ID: 7654758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
